Monopar Therapeutics Inc.
MNPR
$80.13
-$2.43-2.94%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 648.02% | 520.39% | 728.67% | -29.13% | -30.15% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 715.25% | 340.00% | 18.83% | -32.24% | -44.49% |
Total Current Assets | 648.60% | 517.98% | 722.24% | -29.16% | -30.30% |
|
|||||
Total Current Assets | 648.60% | 517.98% | 722.24% | -29.16% | -30.30% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 650.24% | 518.08% | 720.82% | -29.37% | -30.55% |
|
|||||
Total Accounts Payable | 42.29% | 3.96% | 28.27% | -43.34% | -56.45% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 45.35% | 3.96% | 198.98% | -43.34% | -56.45% |
|
|||||
Total Current Liabilities | 45.35% | 3.96% | 198.98% | -43.34% | -56.45% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 52.73% | 3.96% | 198.98% | -43.34% | -56.45% |
|
|||||
Common Stock & APIC | 90.96% | 90.47% | 98.75% | 7.42% | 8.37% |
Retained Earnings | -27.23% | -26.79% | -25.89% | -11.09% | -12.62% |
Treasury Stock & Other | 834.94% | -619.05% | 355.32% | -382.05% | 15.28% |
Total Common Equity | 757.13% | 616.77% | 884.95% | -25.18% | -22.29% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 757.13% | 616.77% | 884.95% | -25.18% | -22.29% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 757.13% | 616.77% | 884.95% | -25.18% | -22.29% |
|